Key facts
- This page summarizes Deborah H. Telman's Form 4 filing for Organon & Co. (OGN).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 05 May 2022, 20:52.
Deborah H. Telman - 04 May 2022 Form 4 Insider Report for Organon & Co. (OGN)
- Reporting relationship
- EVP GC & Corporate Secretary
- Issuer ticker
- OGN
- Reported as of
- 04 May 2022
- Net transaction value
- -$42,140
- SEC form
- 4
- Accepted by SEC
- 05 May 2022, 20:52:25 UTC
- Prior SEC filing
- 04 Apr 2022
- Next SEC filing
- 27 May 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Tarnetta V. Jones, as Attorney-in-Fact for Deborah H. Telman
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Deborah H. Telman filed Form 4 for Organon & Co. (OGN) on 05 May 2022.
Change
- Previous filing in this sequence was filed on 04 Apr 2022.
- Current net transaction value: -$42,140.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
OGN
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +4,431
- Change %
- +97%
- Price
- Shares after
- 8,987
- Date
- 04 May 2022
- Ownership
- Direct
- Footnotes
- F1
OGN
transaction
Common Stock
Tax liability
- Transaction value
- $42,140
- Shares
- -1,299
- Change %
- -14%
- Price
- $32.44
- Shares after
- 7,688
- Date
- 04 May 2022
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
OGN
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -4,431
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 4,431
- Date
- 04 May 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,431
- Exercise price
- Footnotes
- F1, F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU.
Footnote F2
The amount of the RSUs has been slightly adjusted from the Reporting Person's Form 4, dated June 4, 2021, based on the finalization of certain calculations.
Footnote F3
On May 4, 2022, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on May 4, 2023 and May 4, 2024.